Attached files

file filename
8-K - 8-K - ONTO INNOVATION INC.nano-8k_20170801.htm

Exhibit 99.1

 

Nanometrics Incorporated

1550 Buckeye Drive

Milpitas, CA 95035

 

Tel: 408.545.6000

Fax: 408.232.5910

www.nanometrics.com

 

 

Investor Relations Contact:

 

Company Contact:

Claire McAdams

 

Jeffrey Andreson, CFO

Headgate Partners LLC

 

Nanometrics Incorporated

530.265.9899

 

408.545.6143

claire@headgatepartners.com

 

jandreson@nanometrics.com

Nanometrics Reports Second Quarter 2017 Financial Results

Record Revenues Driven by Strength in Memory; Gross Margin Improves over 400bp from the First Quarter

 

MILPITAS, Calif., August 1, 2017 — Nanometrics Incorporated (NASDAQ: NANO), a leading provider of advanced process control systems, today announced financial results for its fiscal second quarter, which ended July 1, 2017.

 

Q2 2017 Highlights:

 

-

Record Revenue Quarter. Strong revenue contributions from 3D-NAND and DRAM, as well as continued Foundry spending, led to record quarterly revenues for Nanometrics.

 

-

Record Adoption of Newest Flagship System, the Atlas® III. Atlas III sales comprised over 50% of all Automated tool revenues in the quarter, evidence of the strongest new product launch in the company’s history. Atlas III systems were shipped to four of the six leading spenders of semiconductor wafer fab equipment (WFE) in the quarter, across every key device type: 3D-NAND, DRAM, and Logic.

 

-

First Revenue Recognized from Domestic China 3D-NAND Manufacturer. A recent competitive win with a new domestic customer in China led to orders for multiple IMPULSE® Integrated Metrology systems, which were shipped and accepted within the second quarter. The IMPULSE systems are being deployed on CMP tools for 3D-NAND devices.

 

-

Expanded Product Offerings for Thin Film Applications and Data Analytics. The company recently announced the adoption of Atlas MPU and Atlas III systems by multiple leading memory manufacturers, for production control of thin film deposition processes in both DRAM and 3D-NAND.The company also announced the release and delivery to multiple customers of NanoDiffract® 4 and SpectraProbe™, the newest additions to its suite of advanced modeling and analytics software products. These new software products provide improved modeling and analysis for the most advanced device structures. First revenues on the expanded product offerings are expected within fiscal 2017.

 

GAAP Results

 

Q2 2017

Q1 2017

Q2 2016

Revenues (Millions)

$64.4

$59.3

$55.8

Gross Margin

52.2%

48.0%

51.0%

Operating Margin

16.5%

9.3%

13.2%

Net Income (loss) (Millions)

$8.3

$5.4

$6.0

Earnings per Diluted Share

$0.32

$0.21

$0.24

 

 

 

 

Non-GAAP Results

 

Q2 2017

Q1 2017

Q2 2016

Gross Margin

52.4%

48.3%

51.8%

Operating Margin

17.2%

9.9%

13.9%

Net Income (Millions)

$7.8

$4.8

$6.5

Earnings per Diluted Share

$0.30

$0.19

$0.26

A reconciliation between GAAP operating results and non-GAAP operating results is provided following the financial statements that are part of this release and on the investor page of Nanometrics' website. Non-GAAP results exclude the impact of amortization of acquired intangibles, restructuring, executive search costs and certain discrete tax items.

 

“The second quarter was very notable for Nanometrics in a number of ways,” commented Dr. Timothy J. Stultz, president and chief executive officer of Nanometrics. “We achieved a new quarterly revenue record, led by strong contributions and continued strength in our 3D-NAND and DRAM memory businesses, and as expected, gross margins increased from the first quarter, are trending up, and are on track to return to our target model ranges in the second half of the year. The Atlas III launch has turned out to be the most successful new product introduction in Nanometrics’ history, and comprised over half of our Automated Metrology tool sales in the second quarter, with expectations that the Atlas III will also comprise over half of our Automated Metrology tool sales for the full year 2017. The adoption rate of this new product has exceeded our earlier expectations, rapidly becoming the OCD tool of choice with our major customers across all key device types.

 


 

Nanometrics Incorporated

1550 Buckeye Drive

Milpitas, CA 95035

 

Tel: 408.545.6000

Fax: 408.232.5910

www.nanometrics.com

 

“During the quarter, we also expanded our software product offerings with the release of the SpectraProbe, a novel model-less analytics software product that increases the capability and utility of our OCD platforms, and the next generation of our NanoDiffract OCD modeling software, further strengthening our leadership in OCD metrology. On the competitive front, we were successful in winning 3D-NAND business at a new domestic China fab with significant future revenue potential. We also expanded our Thin-Film Metrology market position in memory, with competitive wins at multiple customer sites for both DRAM and 3D-NAND process control.

 

“As we look at the full year, our current outlook is consistent with our prior forecasts for meaningful revenue growth in the second half of the year. 3D-NAND spending is looking to be even stronger than we previously expected, with our DRAM outlook also improving since the beginning of the year. Second-half strength in the memory markets will be somewhat moderated by a slightly front-half weighted year for Foundry. In total, we continue to expect second-half revenues will be up 10% from the first half, back-end loaded toward the fourth quarter, with continued expectations for full-year revenue growth outpacing both industry spending and our year-over-year growth in 2016.”

 

Second Quarter 2017 Summary

Revenues for the second quarter of 2017 were $64.4 million, up 8.6% from $59.3 million in the first quarter of 2017, and up 15.5% from $55.8 million in the second quarter of 2016. On a GAAP basis, gross margin was 52.2%, compared to 48.0% in the prior quarter and 51.0% in the year-ago period. Operating income was $10.7 million, compared to $5.5 million in the prior quarter and $7.3 million in the year-ago period. Net income was $8.3 million or $0.32 per diluted share, compared to $5.4 million or $0.21 per diluted share in the prior quarter and $6.0 million or $0.24 per diluted share in the second quarter of 2016.

 

On a non-GAAP basis, which excludes amortization of acquired intangible assets and restructuring, gross margin was 52.4%, compared to 48.3% in the prior quarter and 51.8% in the year-ago period. Non-GAAP operating income was $11.1 million, compared to $5.8 million in the prior quarter and $7.8 million in the second quarter of 2016. Non-GAAP net income, which adjusts for amortization of intangible assets, restructuring, executive search costs and certain discrete tax items, was $7.8 million or $0.30 per diluted share, compared to $4.8 million or $0.19 per diluted share in the prior quarter and $6.5 million or $0.26 per diluted share in the second quarter of 2016.

 

Business Outlook

Management expects third-quarter 2017 revenues in the range of $60 to $64 million. Gross margin is expected to be in the range of 53% to 54% on both a GAAP and non-GAAP basis. Management expects third-quarter operating expenses to range between $23.0 million and $23.5 million on both a GAAP and non-GAAP basis, and earnings in the range of $0.22 to $0.31 per diluted share on both a GAAP and non-GAAP basis.

 

Conference Call Details

A conference call to discuss second quarter 2017 results will be held today at 4:30 p.m. EDT (1:30 p.m. PDT). To participate in the conference call, the dial-in numbers are (877) 374-4041 for domestic callers and (253) 237-1156 for international callers. The conference ID is 51893339. A live and recorded webcast and supplemental financial information will be made available on the investor page of the Nanometrics website at www.nanometrics.com.

 

Use of Non-GAAP Financial Information

The non-GAAP gross profit, gross margin, operating income, operating income margin, net income, net income per share, which exclude certain expenses, charges and special items, and free cash flow, were not prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP). Management uses non-GAAP financial results, which exclude amortization of acquired intangibles assets, restructuring charges, and certain discrete tax items, to evaluate the company’s ongoing performance and to enable comparison to other periods that did not include these items. The company believes the presentation of non-GAAP results is useful to investors for analyzing ongoing business trends, comparing performance to prior periods, and enhancing the investor’s ability to view the company’s results from management’s perspective; however, investors are cautioned that other companies may calculate these measures differently than Nanometrics does, which would limit the usefulness of these financial measures. A table presenting a reconciliation of GAAP results to non-GAAP results is included at the end of this press release and is available on the investor page of the Nanometrics website at www.nanometrics.com.

 

About Nanometrics

Nanometrics is a leading provider of advanced, high-performance process control metrology and inspection systems used primarily in the fabrication of semiconductors and other solid-state devices, including sensors, optoelectronic devices, high-brightness LEDs, discretes and data storage components. Nanometrics’ automated and integrated metrology systems measure critical dimensions, device structures, topography and various thin film properties, including three-dimensional features and film thickness, as well as optical, electrical and material properties. The company’s process control solutions are deployed throughout the fabrication process, from front-end-of-line substrate manufacturing, to high-volume production of semiconductors and other devices, to advanced three-dimensional wafer-level packaging applications. Nanometrics’ systems enable advanced process control for device manufacturers, providing improved device yield at reduced manufacturing cycle time, supporting the accelerated product life cycles in the semiconductor and other advanced device markets. The company maintains its headquarters in Milpitas, California, with sales and service offices worldwide. Nanometrics is traded on NASDAQ Global Select Market under the symbol NANO. Nanometrics’ website is http://www.nanometrics.com.

 

Forward Looking Statements

2/7


 

Nanometrics Incorporated

1550 Buckeye Drive

Milpitas, CA 95035

 

Tel: 408.545.6000

Fax: 408.232.5910

www.nanometrics.com

 

Certain statements in this press release, including those found in the Q2 2017 Highlights, Dr. Stultz’s quote, and under the caption “Business Outlook,” are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those described in this release. Although Nanometrics believes that the expectations reflected in the forward-looking statements are reasonable, actual results could differ materially from these expectations due to a variety of factors, including, but not limited to: decreased levels of industry spending; slowing adoption rate of Nanometrics’ new products; Nanometrics’ inability to gain additional market share, increase sales, ship products as scheduled, achieve customer acceptance of new products, or outperform the industry; decreased demand for Nanometrics’ products; shifts in the timing of customer orders and product shipments; technology adoption rates; changes in customer and product mix; changes in market share; changes in operating expenses; and general economic conditions. For additional information and considerations regarding the risks faced by Nanometrics that could cause actual results to differ materially, see its annual report on Form 10-K for the year ended December 31, 2016, as filed with the Securities and Exchange Commission on March 3, 2017 including under the caption “Risk Factors,” as well as other periodic reports filed with the SEC from time to time. Nanometrics disclaims any obligation to update information contained in any forward-looking statement, except as required by law.

3/7


 

Nanometrics Incorporated

1550 Buckeye Drive

Milpitas, CA 95035

 

Tel: 408.545.6000

Fax: 408.232.5910

www.nanometrics.com

 

NANOMETRICS INCORPORATED

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

 

 

July 1, 2017

 

 

December 31,

2016

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

42,354

 

 

$

47,062

 

Marketable securities

 

 

93,340

 

 

 

82,899

 

Accounts receivable, net

 

 

46,966

 

 

 

39,457

 

Inventories

 

 

48,862

 

 

 

38,837

 

Inventories-delivered systems

 

 

1,674

 

 

 

2,457

 

Prepaid expenses and other

 

 

8,887

 

 

 

5,667

 

Total current assets

 

 

242,083

 

 

 

216,379

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

42,018

 

 

 

44,226

 

Goodwill

 

 

9,756

 

 

 

8,940

 

Intangible assets, net

 

 

309

 

 

 

412

 

Deferred income tax assets

 

 

17,827

 

 

 

17,399

 

Other assets

 

 

399

 

 

 

474

 

Total assets

 

$

312,392

 

 

$

287,830

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

14,926

 

 

$

11,342

 

Accrued payroll and related expenses

 

 

10,615

 

 

 

12,656

 

Deferred revenue

 

 

11,045

 

 

 

9,168

 

Other current liabilities

 

 

7,368

 

 

 

8,047

 

Income taxes payable

 

 

1,258

 

 

 

813

 

Total current liabilities

 

 

45,211

 

 

 

42,026

 

 

 

 

 

 

 

 

 

 

Deferred revenue

 

 

776

 

 

 

816

 

Income taxes payable

 

 

882

 

 

 

841

 

Deferred tax liabilities

 

 

21

 

 

 

20

 

Other long-term liabilities

 

 

375

 

 

 

353

 

Total liabilities

 

 

47,265

 

 

 

44,056

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Common stock

 

 

25

 

 

 

25

 

Additional paid-in capital

 

 

275,908

 

 

 

271,969

 

Accumulated deficit

 

 

(7,449

)

 

 

(22,174

)

Accumulated other comprehensive income (loss)

 

 

(3,357

)

 

 

(6,046

)

Total stockholders’ equity

 

 

265,127

 

 

 

243,774

 

Total liabilities and stockholders’ equity

 

$

312,392

 

 

$

287,830

 

4/7


 

Nanometrics Incorporated

1550 Buckeye Drive

Milpitas, CA 95035

 

Tel: 408.545.6000

Fax: 408.232.5910

www.nanometrics.com

 

NANOMETRICS INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands except per share amounts)

(Unaudited)

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 1, 2017

 

 

June 25, 2016

 

 

July 1, 2017

 

 

June 25, 2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products

 

$

53,576

 

 

$

47,445

 

 

$

101,751

 

 

$

86,659

 

Service

 

 

10,851

 

 

 

8,322

 

 

 

21,990

 

 

 

16,597

 

Total net revenues

 

 

64,427

 

 

 

55,767

 

 

 

123,741

 

 

 

103,256

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs of net revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of products

 

 

25,337

 

 

 

21,736

 

 

 

50,738

 

 

 

39,815

 

Cost of service

 

 

5,364

 

 

 

5,164

 

 

 

10,642

 

 

 

9,648

 

Amortization of intangible assets

 

 

52

 

 

 

442

 

 

 

104

 

 

 

877

 

Restructuring

 

 

53

 

 

 

-

 

 

 

189

 

 

 

                       -

 

Total costs of net revenues

 

 

30,806

 

 

 

27,342

 

 

 

61,673

 

 

 

50,340

 

Gross profit

 

 

33,621

 

 

 

28,425

 

 

 

62,068

 

 

 

52,916

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

9,089

 

 

 

7,511

 

 

 

17,689

 

 

 

15,579

 

Selling

 

 

7,169

 

 

 

7,823

 

 

 

15,053

 

 

 

15,072

 

General and administrative

 

 

6,591

 

 

 

5,755

 

 

 

12,898

 

 

 

11,175

 

Amortization of intangible assets

 

 

-

 

 

 

-

 

 

 

-

 

 

 

24

 

Restructuring

 

 

120

 

 

 

-

 

 

 

268

 

 

 

-

 

Total operating expenses

 

 

22,969

 

 

 

21,089

 

 

 

45,908

 

 

 

41,850

 

Income from operations

 

 

10,652

 

 

 

7,336

 

 

 

16,160

 

 

 

11,066

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

3

 

 

 

12

 

 

 

4

 

 

 

21

 

Interest expense

 

 

(19

)

 

 

(67

)

 

 

(59

)

 

 

(184

)

Other income (expense), net

 

 

274

 

 

 

(394

)

 

 

271

 

 

 

(169

)

Total other income (expense), net

 

 

258

 

 

 

(449

)

 

 

216

 

 

 

(332

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

 

10,910

 

 

 

6,887

 

 

 

16,376

 

 

 

10,734

 

Provision for income taxes

 

 

2,622

 

 

 

856

 

 

 

2,736

 

 

 

1,236

 

Net income

 

$

8,288

 

 

$

6,031

 

 

$

13,640

 

 

$

9,498

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.33

 

 

$

0.25

 

 

$

0.54

 

 

$

0.39

 

Diluted

 

$

0.32

 

 

$

0.24

 

 

$

0.53

 

 

$

0.38

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares used in per share calculation:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

25,307

 

 

 

24,524

 

 

 

25,220

 

 

 

24,416

 

Diluted

 

 

25,906

 

 

 

24,927

 

 

 

25,880

 

 

 

24,773

 

 

 

5/7


 

Nanometrics Incorporated

1550 Buckeye Drive

Milpitas, CA 95035

 

Tel: 408.545.6000

Fax: 408.232.5910

www.nanometrics.com

 

NANOMETRICS INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

 

Six Months Ended

 

 

 

July 1, 2017

 

 

June 25, 2016

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net income

 

$

13,640

 

 

$

9,498

 

Reconciliation of net income to net cash from operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

3,552

 

 

 

4,305

 

Stock-based compensation

 

 

4,327

 

 

 

3,432

 

Loss on disposal of fixed assets

 

 

98

 

 

 

128

 

Inventory write down

 

 

1,015

 

 

 

1,046

 

Deferred income taxes

 

 

798

 

 

 

(30

)

Changes in fair value of contingent consideration

 

 

-

 

 

 

95

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(4,720

)

 

 

(14,277

)

Inventories

 

 

(10,090

)

 

 

6,457

 

Inventories-delivered systems

 

 

783

 

 

 

(6,737

)

Prepaid expenses and other

 

 

(947

)

 

 

(151

)

Accounts payable, accrued and other liabilities

 

 

(521

)

 

 

(1,511

)

Deferred revenue

 

 

1,837

 

 

 

12,080

 

Income taxes payable

 

 

486

 

 

 

(1,115

)

Net cash provided by operating activities

 

 

10,258

 

 

 

13,220

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Payment for acquisition of certain assets

 

 

(2,000

)

 

 

-

 

Sales of marketable securities

 

 

27,391

 

 

 

-

 

Maturities of marketable securities

 

 

40,923

 

 

 

21,816

 

Purchases of marketable securities

 

 

(78,787

)

 

 

(12,880

)

Purchase of property, plant and equipment

 

 

(1,536

)

 

 

(2,528

)

Net cash provided by (used in) investing activities

 

 

(14,009

)

 

 

6,408

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Payments to Zygo Corporation related to acquisition

 

 

-

 

 

 

(315

)

Proceeds from sale of shares under employee stock option and purchase plans

 

 

2,865

 

 

 

3,466

 

Taxes paid on net issuance of stock awards

 

 

(3,392

)

 

 

(1,288

)

Net cash provided by (used in) financing activities

 

 

(527

)

 

 

1,863

 

Effect of exchange rate changes on cash and cash equivalents

 

 

(430

)

 

 

387

 

Net increase in cash and cash equivalents

 

 

(4,708

)

 

 

21,878

 

Cash and cash equivalents, beginning of period

 

 

47,062

 

 

 

38,154

 

Cash and cash equivalents, end of period

 

$

42,354

 

 

$

60,032

 

 

 

 


6/7


 

Nanometrics Incorporated

1550 Buckeye Drive

Milpitas, CA 95035

 

Tel: 408.545.6000

Fax: 408.232.5910

www.nanometrics.com

 

NANOMETRICS INCORPORATED

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three Months Ended

 

 

 

July 1, 2017

 

 

April 1, 2017

 

 

June 25, 2016

 

Reconciliation of GAAP gross profit and gross margin to non-GAAP gross profit and gross margin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP gross profit and gross margin, respectively

 

$

33,621

 

 

 

52.2

%

 

$

28,447

 

 

 

 

 

48.0

%

 

$

28,425

 

 

 

51.0

%

Non-GAAP adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring included in cost of revenues

 

 

53

 

 

 

0.1

%

 

 

136

 

 

 

 

 

0.2

%

 

 

-

 

 

 

-

 

Amortization of intangible assets

 

 

52

 

 

 

0.1

%

 

 

52

 

 

 

 

 

0.1

%

 

 

442

 

 

 

0.8

%

Non-GAAP gross profit and gross margin, respectively

 

$

33,726

 

 

 

52.4

%

 

$

28,635

 

 

 

 

 

48.3

%

 

$

28,867

 

 

 

51.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of GAAP operating income to non-GAAP operating income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP operating income and operating margin, respectively

 

$

10,652

 

 

 

16.5

%

 

$

5,508

 

 

 

 

 

9.3

%

 

$

7,336

 

 

 

13.2

%

Non-GAAP adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of intangible assets included in cost of revenues

 

 

52

 

 

 

0.1

%

 

 

52

 

 

 

 

 

0.1

%

 

 

442

 

 

 

0.7

%

Amortization of intangible assets included in operating expenses

 

 

-

 

 

-

 

 

 

-

 

 

 

 

 

0.0

%

 

 

-

 

 

-

 

Restructuring included in cost of revenues

 

 

53

 

 

 

0.1

%

 

 

136

 

 

 

 

 

0.2

%

 

 

-

 

 

-

 

Restructuring included in operating expenses

 

 

120

 

 

 

0.2

%

 

 

148

 

 

 

 

 

0.3

%

 

 

-

 

 

-

 

Executive search costs

 

 

230

 

 

 

0.3

%

 

 

-

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

Total non-GAAP adjustments to operating income

 

 

455

 

 

 

0.7

%

 

 

336

 

 

 

 

 

0.6

%

 

 

442

 

 

 

0.7

%

Non-GAAP operating income and operating margin, respectively

 

$

11,107

 

 

 

17.2

%

 

$

5,844

 

 

 

 

 

9.9

%

 

$

7,778

 

 

 

13.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of GAAP net income to non-GAAP net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net income

 

$

8,288

 

 

 

 

 

 

$

5,352

 

 

 

 

 

 

 

 

$

6,031

 

 

 

 

 

Non-GAAP adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total non-GAAP adjustments to non-GAAP operating income

 

 

455

 

 

 

 

 

 

 

336

 

 

 

 

 

 

 

 

 

442

 

 

 

 

 

Discrete tax items and tax effect of non-GAAP adjustments

 

 

(948

)

 

 

 

 

 

 

(901

)

 

 

 

 

 

 

 

 

-

 

 

 

 

 

Non-GAAP net income

 

$

7,795

 

 

 

 

 

 

$

4,787

 

 

 

 

 

 

 

 

$

6,473

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net income per diluted share

 

$

0.32

 

 

 

 

 

 

$

0.21

 

 

 

 

 

 

 

 

$

0.24

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP net income per diluted share

 

$

0.30

 

 

 

 

 

 

$

0.19

 

 

 

 

 

 

 

 

$

0.26

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares used in diluted net income per share calculation

 

 

25,906

 

 

 

 

 

 

 

25,833

 

 

 

 

 

 

 

 

 

24,927

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of net cash provided by operating activities to free cash flow

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net cash provided by operating activities

 

$

7,183

 

 

 

 

 

 

$

3,075

 

 

 

 

 

 

 

 

$

12,721

 

 

 

 

 

Purchase of property and equipment

 

 

(1,489

)

 

 

 

 

 

 

(47

)

 

 

 

 

 

 

 

 

(1,918

)

 

 

 

 

Free cash flow

 

$

5,694

 

 

 

 

 

 

$

3,028

 

 

 

 

 

 

 

 

$

10,803

 

 

 

 

 

 

7/7